Malaria and children: Progress in intervention coverage - Unicef

More documents

Recommendations

Info

Statistical table 8 (continued) 67 Country Year Any antimalarial Chloroquine medicine a Percentage of febrile children under age five treated with Antimalarial medicines Non-antimalarial medicines SP/ Amodiaquine Fansidar b ACT c Quinine Other Aspirin Ibuprofen Paraceta mol Namibia 2000 14 14 — — — — — — — — 22 — DHS 2000 Nicaragua 2001 2 2 0 — — — — 6 1 81 20 1 DHS 2001 Niger 2000 48 48 0 — — — — 30 — 15 19 2 MICS 2000 Niger 2006 33 29 1 — 1 4 — — — — — — DHS 2006 Rwanda 2000 9 5 1 — — 3 — — — — — — DHS 2000 Rwanda 2000 13 7 2 — — 4 — — — 11 15 40 MICS 2000 Rwanda 2005 12 — 4 — 6 5 — — — — — — DHS 2005 São Tomé and Principe 2000 61 61 1 — — — — — — 76 0 2 MICS 2000 São Tomé and Principe 2006 25 2 1 6 12 3 1 5 2 75 10 1 MICS 2006 Senegal 2000 36 36 1 — — 6 — — — 49 19 4 MICS 2000 Senegal 2005 27 17 1 — 8 2 — — — — — — DHS 2005 Sierra Leone 2000 61 60 4 — — — — — — 66 43 7 MICS 2000 Sierra Leone 2006 52 46 1 1 2 5 4 21 2 68 25 7 MICS 2006 Somalia 2006 8 6 2 1 0 0 0 4 0 5 1 1 MICS 2006 Sudan 2000 50 49 1 — — — — — — 12 11 1 MICS 2000 Swaziland 2000 26 23 6 — — — — — — 59 0 4 MICS 2000 Tajikistan 2005 2 0 0 0 0 0 1 16 0 73 11 3 MICS 2005 Tanzania, United Rep. of 2004–2005 58 2 24 2 22 12 — — — — — — DHS 2004–2005 Timor-Leste 2002 47 43 12 — — 3 12 — — 66 11 1 MICS 2002 Togo 2000 60 59 3 — — — — — — 65 39 2 MICS 2000 Togo 2006 48 32 3 1 6 9 8 3 1 54 26 3 MICS 2006 Viet Nam 2000 7 4 1 — — 2 — — — 50 24 21 MICS 2000 Viet Nam 2006 3 0 2 0 0 0 0 3 1 38 33 21 MICS 2006 Zambia 1999 58 56 2 — — 2 — — — 60 2 18 MICS 1999 Zambia 2001–2002 52 50 2 — — 2 — — — — 62 2 DHS 2001–2002 Zambia 2006 58 — 33 13 — 5 12 — — — — — MIS 2006 Zimbabwe 2005–2006 5 4 1 — — 0 — — — — — — DHS 2005–2006 Other Don’t know Source d Malaria and children Statistical annex — not available. a. Values may not equal the sum of the values by type of antimalarial medicine because children may have taken more than one antimalarial medicine to treat a malaria episode. b. Sulfadoxine-pyrimethamine/Fansidar. c. Artemisinin-based combination therapy. d. DHS is Demographic and Health Survey, MICS is Multiple Indicator Cluster Survey and MIS is Malaria Indicator Survey.
68 Statistical table 9 Pregnant women receiving intermittent preventive treatment, by background characteristics Percentage of pregnant women ages 15–49 receiving intermittent preventive treatment Residence Wealth index quintile Country Year Total Urban Rural Poorest Second Middle Fourth Richest Source a Benin 2006 3 3 2 — — — — — DHS 2006 (Preliminary report) Burkina Faso 2006 1 2 1 2 1 1 1 2 MICS 2006 Cameroon 2006 6 8 4 4 3 7 7 10 MICS 2006 Central African Republic 2006 9 15 5 2 4 7 14 19 MICS 2006 Côte d’Ivoire 2006 8 10 7 7 7 6 11 11 MICS 2006 Gambia, The 2006 33 31 34 30 33 31 35 34 MICS 2006 Ghana 2003 1 1 1 1 1 1 1 1 DHS 2003 Ghana 2006 27 35 24 23 21 25 33 41 MICS 2006 Guinea 2005 3 8 1 1 1 2 2 11 DHS 2005 Guinea Bissau 2006 7 9 7 4 6 8 12 9 MICS 2006 Kenya 2003 4 4 4 3 5 5 3 4 DHS 2003 Malawi 2004 43 51 42 39 38 44 44 54 DHS 2004 Malawi 2006 45 52 44 40 42 45 46 52 MICS 2006 Niger 2006 0 1 0 0 0 0 0 1 DHS 2006 Nigeria 2003 1 — — — — — — — DHS 2003 Rwanda 2005 0 1 0 0 0 0 0 1 DHS 2005 Senegal 2005 9 11 8 6 7 10 11 12 DHS 2005 Sierra Leone 2005 2 5 1 0 1 1 3 5 MICS 2005 Somalia 2006 1 1 1 b 1 1 1 1 1 MICS 2006 Tanzania, United Rep. of 2004–2005 22 29 20 18 21 18 25 30 DHS 2004–2005 Togo 2006 18 18 18 12 17 17 20 25 MICS 2006 Uganda 2006 17 18 16 — — — — — DHS 2006 (Preliminary report) Zambia 2006 61 71 56 58 71 61 78 — MIS 2006 Zimbabwe 2005–2006 6 3 8 7 8 8 7 1 DHS 2005–2006 — not available. Note: Intermittent preventive treatment consists of at least two doses of sulfadoxine-pyrimethamine/Fansidar received during antenatal care visits. a. DHS is Demographic and Health Survey, MIS is Malaria Indicator Survey and MICS is Multiple Indicator Cluster Survey. b. Data are for non-urban areas, including rural and nomad populations.
Page 1 and 2:
Malaria & children Progress in inte
Page 3 and 4:
Copyright © 2007 by the United Nat
Page 5 and 6:
Acknowledgements This report was pr
Page 8 and 9:
1 Executive summary An estimated 3
Page 10:
3 30 25 20 15 10 5 0 Figure 2 Globa
Page 13 and 14:
6 Bonnie Gillespie/Voices for a Mal
Page 15 and 16:
8 Background on malaria Where is th
Page 18 and 19:
11 Progress in the fight against ma
Page 20 and 21:
Large increases in funding and atte
Page 22 and 23:
The number of nets procured by UNIC
Page 24 and 25: Although data are limited, more tha
Page 26 and 27: Rapid gains have been made in insec
Page 28 and 29: Since 2003 nearly all sub- Saharan
Page 30 and 31: Many countries still treat a large
Page 32 and 33: Since around 2005 both production o
Page 34 and 35: Coverage of intermittent preventive
Page 36 and 37: Countries are now accelerating thei
Page 38 and 39: New medicines are urgently needed t
Page 40: 33 2000 2006 Figure 3 Togo has seen
Page 43 and 44: 36 2005 Alfredo L. Fort/Courtesy of
Page 45 and 46: 38 M. Hallahan/Sumitomo Chemical-Ol
Page 47 and 48: 40 Malaria intervention coverage da
Page 49 and 50: 42 spraying rather than insecticide
Page 51 and 52: 44 Republic, Ecuador, Egypt, El Sal
Page 53 and 54: 46 26. Gazsi 2007. 27. Novartis Int
Page 55 and 56: 48 on Morbidity, Mortality, CD4-Cel
Page 57 and 58: Contents Statistical annex Statisti
Page 59 and 60: 52 Statistical table 1 (continued)
Page 63 and 64: 56 Statistical table 2 Household av
Page 65 and 66: 58 Statistical table 3 Household av
Page 73: 66 Statistical table 8 Children wit
Page 78: This report assesses progress in ma
show all

Malaria and children: Progress in intervention coverage - Unicef

Create successful ePaper yourself

Delete template?

Save as template?